Atossa Therapeutics, Inc. (ATOS) Dividend History

Atossa Therapeutics, Inc. (ATOS) is a biotechnology company focused on developing targeted treatments for breast cancer, hormone-related issues, and other serious medical conditions. The company is particularly known for its research into novel therapies involving breast health and hormone modulation, aiming to address unmet medical needs through innovative drug delivery methods and clinical development efforts.

10202 5th Avenue Ne, Seattle, WA, 98125
Phone: 206.588.0256
Website: https://www.atossatherapeutics.com

Dividend History

Atossa Therapeutics, Inc. currently does not pay dividends

Company News

Atossa Therapeutics CEO to Discuss Clinical Progress and Upcoming Milestones at 27th Annual H.C. Wainwright Global Investment Conference

Atossa Therapeutics' CEO Dr. Steven Quay will participate in a fireside chat at the 27th Annual H.C. Wainwright Global Investment Conference, discussing clinical progress of their lead product (Z)-endoxifen, a potential breast cancer treatment and prevention therapy.

Benzinga
Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit

Atossa Therapeutics, a clinical-stage biopharmaceutical company, announced that its Vice President of Investor and Public Relations will participate in a virtual fireside chat at the 2024 Maxim Healthcare Virtual Summit.

GlobeNewswire Inc.
Are Medical Stocks Lagging Alvotech (ALVO) This Year?

Here is how Alvotech (ALVO) and Atossa Genetics Inc. (ATOS) have performed compared to their sector so far this year.

Zacks Investment Research

Featured Companies: ALVO
Best Penny Stocks To Buy? 4 Stocks Under $3 To Watch This Week

Penny stocks under $3 to watch this week. The post Best Penny Stocks To Buy? 4 Stocks Under $3 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: AMRX
Can Atossa Therapeutics Stock Keep Climbing?

Investors want to know if this clinical-stage cancer drug developer can keep putting up big gains.

The Motley Fool

Page data last updated 09/07/2025 04:16:28 UTC